A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia-Reference-Cited by-同舟云学术

A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia

Published:2022-06-03 Issue:6 Volume:15 Page:671-688
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Gómez-Zorrilla Silvia¹²³⁴^ORCID,Sendra Elena¹²^ORCID,Horcajada Juan P.¹²³⁴^ORCID

Affiliation:

1. Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain

2. Infectious Pathology and Antimicrobals Research group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain

3. Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain

4. Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2100346

Reference84 articles.

1. Trends in Hospitalizations for Pneumonia Among Persons Aged 65 Years or Older in the United States, 1988-2002

2. Clinical and economic burden of community-acquired pneumonia among adults in Europe

3. Clinical and Economic Burden of Community-Acquired Pneumonia among Adults in the Czech Republic, Hungary, Poland and Slovakia

4. World Health Organization. Global Health Estimates; 2019 [cited 2021 Dec 12]. Available from: https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf

5. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates;Journal of Antimicrobial Chemotherapy;2024-08-10

2. Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia;Seminars in Respiratory and Critical Care Medicine;2024-02-01

3. Updated Review on Clinically-Relevant Properties of Delafloxacin;Antibiotics;2023-07-28